DOJ Charges 76 Medical Professionals In Massive Healthcare Fraud Investigation

The Department of Justice (DOJ) has announced significant criminal charges against nearly 200 individuals involved in various healthcare fraud schemes. These fraudulent activities, spanning 32 federal districts, are believed to have caused $2.75 billion in intended losses and $1.6 billion in actual losses. Among those charged, 76 are doctors, nurse practitioners, and other licensed medical professionals.

The 2024 National Health Care Fraud Enforcement Action led to the seizure of more than $231 million in assets, including cash, luxury vehicles, and gold. This extensive investigation has revealed a broad range of fraudulent schemes that have had a significant impact on the healthcare system and taxpayers.

Principal Deputy Assistant Attorney General Nicole M. Argentieri, head of the DOJ’s Criminal Division, highlighted the extensive nature of the fraud and its detrimental effects. “Health care fraud affects every American,” Argentieri stated. “It siphons off hard-earned tax dollars meant to provide care for the vulnerable and disabled. In doing so, it also raises the cost of care for all patients.”

The fraudulent activities uncovered include a $900 million scheme involving amniotic wound grafts, the unlawful distribution of millions of Adderall pills by a digital technology company, and over $90 million in fraud linked to the distribution of adulterated HIV medications. Other significant frauds involved $146 million in addiction treatment schemes, $1.1 billion in telemedicine and laboratory fraud, and $450 million in various health care and opioid fraud schemes.

One particularly alarming case involved mislabeled HIV medication, resulting in a patient consuming an antipsychotic drug instead of their prescribed medication, causing them to lose consciousness for 24 hours. Additionally, seven individuals associated with Done Global, a telehealth company, were charged with illegally distributing Adderall. A nurse practitioner in Florida reportedly prescribed over 1.5 million pills without patient interaction.

Argentieri emphasized the DOJ’s commitment to combating health care fraud, stating, “The Criminal Division is committed to rooting out health care fraud, wherever it may be found, no matter who commits it.” She underscored the importance of using all available tools to uncover misconduct and hold wrongdoers accountable, regardless of their position or profession.

This comprehensive enforcement action demonstrates the DOJ’s dedication to protecting the integrity of the healthcare system and ensuring that resources are used appropriately to benefit patients in need.